ÄúÓÐÐÂÐÅ

 
[¸æ¼±] ¾´Ñû²Î¼Ó¿çѧÃÅ¿ÆѧPKÀÞ̨¾ºÈü(1/19)
#1
lala
·¢ÐÅÕ¾: ÅúÌßÌßʵҵ (ptt.cc )
¸÷λͬѧ´ó¼ÒºÃ£º
²»ÖªµÀÊÇ·ñÒòΪÌìÆøÌ«¹ý춺®Àä ±¾»î¶¯Ä¿Ç°±¨ÃûÈËÊý²»×ã >"<
¼Æ»­·¢±íÄÚÈݲ»½öÓÐ̨´óµÄͬѧ¡¢»¹Óж«»ª´óѧ¡¢Ì¨Íåʦ¡õ´óѧÒÔ¼°ÑôÃ÷´óѧ½øÐпçÁìÓò
¿çУ½»Á÷£¬±¾»î¶¯ÖÐÎ籸ÓвͺС¢ÏÂÎçÓвèµã£¬È«³Ì¶¼ÓÐůºôºôµÄ²èË®Ìṩร¡
»¶Ó­Í¬Ñ§Ó»Ô¾²Î¼Ó£¬Îª·¢±í²ÎÈü¶ÓÎé¼ÓÓÍ´òÆø
²¢ÔöÉè×î¼Ñ¹ÛÖÚ½±£¬µÃ½±¶ÓÎéÓÉÄú¾ö¶¨£¡
±¨ÃûÈÕÆÚÑÓ³¤ÖÁ1/17£¬Ï£ÍûÓÐÐËȤµÄͬѧÄܹ»¾¡¿ì±¨Ãû£¡

             ¡î¡ï¡î¡¸´óѧ¿çѧÃÅ¿ÆѧÈ˲ÅÅàÓýÏνӼƻ­¡¹¡î¡ï¡î

    ÒÔ´óÒ»¡¢´ó¶þѧÉúΪÖ÷ÒªÅàÓý¶ÔÏ󣬲¢ÏνÓÖнÌ˾¡¸¸ßÖÐѧÉú¿ÆѧÑо¿È˲Å
ÅàÓý¼Æ»­¡¹¼°¹ú¿Æ»á¡¸²¹Öú´óרѧÉú²ÎÓëרÌâÑо¿¼Æ»­¡¹Ö®È˲ÅÅàÓý¼Æ»­£¬ÒÔÁ¬
¹áÈý½×¶ÎÅàÓý¼Æ»­Ö®ÊµÊ©¡£

    Òò´Ë£¬±¾»î¶¯»¶Ó­´óѧÉú¼°¸ßÖÐÉúÝ°ÁÙ²ÎÓ룬Á˽â´óѧ¿çѧ¿ÆºÏ×÷ÔË×÷·½Ê½
£¬²¢»¶Ó­¼ÓÈë±¾¼Æ»®â·°éÍŶӣ¬ÍØÕ¹ÊÓÒ°£¬Ôö¹ã¼ûÎÅ¡£»î¶¯Ê±¼ä¸÷У¾ùÒѷź®¼Ù
£¬Ï£Íû¸÷ÁìÓòʦÉúÄÜÓ»Ô¾²ÎÓë¡£

   ¡ó¡ô¡ó¡ô¡ó¡ô¡ó¡ô¡ó¡ô¡ó¡ô¡ó¡ô¡ó¡ô¡ó¡ô¡ó¡ô¡ó¡ô¡ó¡ô¡ó¡ô¡ó¡ô¡ó¡ô¡ó¡ô

¡¾»î¶¯Ê±¼ä¡¿100Äê1ÔÂ19ÈÕ

¡¾»î¶¯µØµã¡¿¹úÁ¢Ì¨Íå´óѧӦÓÃÁ¦Ñ§Ñо¿Ëù  ´óÌü/R100¹ú¼Ê»áÒéÌü

¡¾Ö÷°ìµ¥Î»¡¿´óѧ¿çѧÃÅ¿ÆѧÈ˲ÅÅàÓýÏνӼƻ­ ±±ÇøÍƶ¯ÖÐÐÄ

¡¾²ÎÓë¶ÔÏó¡¿±±Çøⷰ飬»¶Ó­¶Ôì¶100Äê¿çѧÃżƻ­¼°¿çÁìÓòÒéÌâÓÐÐËȤ֮ÈËÊ¿²Î¼Ó¡£

¡¾ÏßÉϱ¨Ãû¡¿http://case.ntu.edu.tw/NCISE/s4.php £¨1/16½ØÖ¹£©
            »¶Ó­·Ç¼Æ»­â·°éÝ°Áٲιۣ¬ÏßÉϱ¨ÃûÃâµÇÈë

¡¾²ÎÈü¶ÓÎé¡¿http://case.ntu.edu.tw/ncise/?p=5207

 ×¢£º±¾»î¶¯±¸ÓÐÊÖ²áÓë²ÍºÐ£¬µ«ÈôÓÐ䱨ÃûÕ߶îÍâ²Î¼Ó£¬Ôò²»ÓèÌṩ£¬²¢Çë×Ô±¸»·±£±­
¡¢²Í¾ß¡£ÏÖ³¡×ùλÓÐÏÞ£¬¾´ÇëÌáÔçÈ볡¡£

¡ï¡î¡ï¡î¡ï¡î¡ï¡î¡ï¡î¡ï¡î¡ï¡î ¾ºÈüÄÚÈÝ ¡ï¡î¡ï¡î¡ï¡î¡ï¡î¡ï¡î¡ï¡î¡ï¡î

    ×ܾöÈüÒÑåàÑ¡°Ë¶Ó½ú¼¶£¬¿ÆѧÀÞ̨ÓûÅàÑøͬѧÃÇ¿çÁìÓò¶Ô»°ÄÜÁ¦£¬³ýÁËÓÐÌõ²»Îɵر¨
¸æ¼Æ»­¹±Ï׳ɹûÍ⣬¸üÐèñöÌýÆäËûÁìÓò¼Æ»­ÄÚÈÝ£¬½ø¶øÌá³öºËÐÄÎÊ´ð£¬Óɼƻ­¼ä±Ë´ËÎÊ´ð
£¬ÏÔ¶²ÎÈü¶ÓÎé×¼±¸³Ì¶ÈºÍÁÙ³¡·´Ó¦ÄÜÁ¦£¬Î¨ÓÐͬʱ¾ß±¸Ìý˵¶Áд֮ȫ·½Î»¿ÆѧݼӢʼÄÜ
³ÉΪ¿ÆѧÀÞ̨֮×ܹھü¡£

¡ï¡î¡ï¡î¡ï¡î¡ï¡î¡ï¡î¡ï¡î¡ï¡î ·¢±íÄÚÈÝ ¡ï¡î¡ï¡î¡ï¡î¡ï¡î¡ï¡î¡ï¡î¡ï¡î

¡ò¡òÆô·¢Ñ§Ï°Ö®»ù´¡ÎïÀí-¹¤³Ì-ҽѧ¿çѧÃÅ´´Ð½̲ÄÓëʵÑ鿪·¢¡ò¡ò
¼Æ»­Ö÷³ÖÈË      ¸µÕÑÃú/¹úÁ¢Ì¨Íå´óѧÎïÀíѧϵ
¼Æ»­·¢±íÈË      ³Â½¨°²/ÎïÀíËù˶¶þ

±¾¼Æ»­·Ö³ÉÈý¸ö²¿·Ýͬʱ½øÐУº1. ´´ÐÂÑÝʾʵÑé2.¿ª·¢Ì½¾¿×¨ÌâʵÑé3.ÖÆ×÷ÉúÒ½ÎïÀí½Ì
²ÄÑÝʾʵÑ鲿·Ý£ºÄ¿Ç°¿ª·¢28ÏîÑÝʾʵÑ鹩ÉÏ¿ÎʹÓ㬿ÉÌá¸ßѧÉúÐËȤ£¬¹ÄÀøѧÉú˼¿¼Æä
¿ÆѧԭÀí¡£Ì½¾¿×¨ÌâʵÑ鲿·Ý£ºÍê³É5¸öÉúÒ½Ïà¹ØʵÑ飬Æô·¢Ñ§ÉúµÄÖ÷¶¯ÐԺʹ´ÔìÐÔ¡£½Ì
²Ä²¿·Ý£ºÍê³ÉÒ»·ÝÉúÒ½-¹¤³Ì-ÆÕͨÎïÀíÉϿβο¼½²Òå
±¾¼Æ»­Ò²Ê¹ÓÃÁ¢¼´»ØÀ¡½Ìѧϵͳ£¨interactive response system£¬IRS£©£¬´ÓÊÂͬ٭»¥¶¯
Óë̽¾¿Ê½½Ìѧ֮´´Ð½Ìѧ·½·¨¡£½ñÄê¾Ù°ìÆÕͨÎïÀí»¥¶¯½ÌѧÓë´´ÒâʵÑéÑÐÌֻᣬÑûÇëÃÀ¹ú
×Üͳ½Ü³öÇàÄê½±ÖªÃû¿Æ½ÌѧÕßEric Mazur(University of Harvard,USA)´Ù³É¹úÄÚÎïÀíÓë
ʵÑé½ÌѧÐÂ˼ά²¢Óë¹ú¼Ê½Ó¹ì¡£

¡ò¡òÓлúȾÁÏÃô»¯Ì«ÑôÄܵç³Ø¿çѧÃſƼ¼È˲ÅÅàÓý¼Æ»­¡ò¡ò
ÓлúȾÁÏÃô»¯Ì«ÑôÄܵç³Ø¿çѧÃſƼ¼È˲ÅÅàÓý¼Æ»­
¼Æ»­Ö÷³ÖÈË Íô¸ù¡õ/»¯Ñ§Ïµ
¼Æ»­·¢±íÈË ÀîÙøÆæ/»¯Ñ§Ïµ´óÈý Íõ¼Î°²/»¯Ñ§Ïµ´óÈý ºúÔªÕý/»¯Ñ§Ïµ´óÈý

ÔÚ½ñÄê¶ÈµÄ¼Æ»­Ö®ÖУ¬ÎÒÃÇѧϰÁË·Ö×ӵĻ¯Ñ§½á¹¹ÓëËü±¾ÉíµÄÎïÀí¼°»¯Ñ§ÐÔÖʵĹØÁ¬£¬²¢
ÇÒ½¨Á¢Á˶ÔDSSC ²ÄÁϵķÖ×ÓÉè¼Æ¸ÅÄÁ˽â½á¹¹Éè¼ÆµÄÖØÒªÐÔ¡£³ý´ËÖ®ÍâÎÒÃÇ»¹Êµ¼ÊºÏ
³É²ÄÁÏ£¬Ò²Ñ§µ½Á˺ϳɹý³ÌÖÐËùÐèµÄÓлú»¯Ñ§ÖªÊ¶¡¢²Ù×÷¼¼ÊõÓë´¿»¯¼°ÐÔÖʵġõ¶¨¡£½ÓÏÂ
À´¾­ÓɹâÎïÀíÒÔ¼°µç»¯Ñ§µÄ²âÊÔÑéÖ¤ÎÒÃǵÄÖÆ×÷µÄ·Ö×Ó·ûºÏÉè¼ÆµÄ¸ÅÄî¡£
×îááʵ¼Ê½«ºÏ³É³öÀ´µÄ²ÄÁÏÄÃÈ¥²ÎÓëÖÆ×ö³öDSSC Ôª¼þ¡£ÔÚÕâ¸ö¹ý³ÌÖÐÎÒÃǼûʶµ½Ò»¸öÍê
ÕûµÄÔª¼þÖƱ¸³ýÁ˲ÄÁϵÄÉè¼ÆÍ⣬µç¼«µÄÖÆ×÷ÓëÔª¼þµÄ·â×°¶¼ÓкÜÉîµÄ֪ʶÓë¼¼ÇÉÔÚÆäÖÐ
¡£×îÖÕÎÒÃÇÖÆ×÷³öÀ´µÄÔª¼þÔÚAM1.5 µÄ¹âÇ¿¶Èϳɹ¦µÄÈõçÉÈת¶¯£¬ÎÒÃǸе½ºÜÐË·Ü£¬Òò
ΪÕâ±íʾÕû¸öÁ÷³ÌµÄ¶¯×÷½ÔÊÇÕýÈ·µÄ¡£

¡ò¡òÄÔ¹¦ÄÜÓ°ÏñÔìÓ°Ö®»ù´¡ÑµÁ·£­Éñ¾­ÉúÎï¡ò¡ò
¼Æ»­Ö÷³ÖÈË ÑÏÕð¶«/ ¶¯ÎïËù
¼Æ»­·¢±íÈË Éú¿ÆÈýÒ¶¿¡ÑÔ¡¢Éú¿ÆÈýÀîê¿¡õ¡¢µç»úÈýÕżÎÈÝ¡¢µç»úÈýÕŸ»½Ü

Ê×ÏÈÎÒÃÇ̽ÌÖÒ»¸öÌÛÍ´´Ì¼¤ÊÇÈçºÎÔì³Éµ¥Ò»Éñ¾­Ôª·ÅµçƵÂʵĸı䣬²¢Ï£Íû½åÓɽ¨Á¢¼òµ¥
¶¨Á¿µÄͼÐÎʶ±ð·¨(pattern recognition)À´·ÖÀàÉñ¾­Ï¸°ûµÄ״̬£¬²¢º­¸ÇÁËËüµÄ·ÅµçÄ£
ʽ(firing pattern)ÌØÐÔ£¬²¢ÇÒ·¢ÏÖÔÚÄÚ²àÊÓÇðµÄÇøÓò×Ô·¢ÐÔ״̬ϾÍÓÐÔ¼30%µÄϸ°ûÊÇ
»áÓв¨¶¯¸Ä±ä£¬ÓÐ70%ÔòÊDz»Ëæʱ¼ä±ä¶¯£¬È»ááÔÚÕâ70%Ö®ÖÐÖ»ÓÐÔ¼5%µÄϸ°û»áÔÚÈÈÍ´´Ì¼¤
ÏŸıä״̬¡£

µÚ¶þ²¿·ÝÎÒÃÇÒÔ´óÊóÏÂÑÀ²ÛÉñ¾­ºá¶Ï×÷ΪÉñ¾­Í´Ñо¿µÄ¶¯ÎïÄ£ÐÍ£¬Ì½ÌÖ´ËÀàÂýÐÔÌÛÍ´¶Ô¸ö
ÌåµÄÉñ¾­Ôª»îÐÔÒÔ¼°ÐÐΪ±íÏÖÔì³ÉµÄÓ°Ï졣Ŀǰ³ýÁË·¢ÏÖÆäÐÐΪÓëÉñ¾­Ôª»îÐÔÔÚÊõááÓÐËù
±ä»¯Ö®Í⣬»¹·¢ÏÖÔÚÉñ¾­Ôª»îÐÔ·½Ã棬ÖÐÊà±ÈÖܱßÏȳöÏָı䡣

×îááÒ»¸ö²¿·Ý£¬ÎÒÃÇÒª¿´µÄÊÇÌÛÍ´ÔÚ¸öÌåÖÐËùÒýÆðµÄ·´Ó¦ÊÇ·ñ»áÄܹ»´«µÝµ½ÁíÒ»¸ö¸öÌåÉÏ
¡£Õⲿ·ÝµÄʵÑéÎÒÃÇ·¢ÏÖµ±´óÊó¹Û²ìµ½ÁíÒ»Ö»´óÊóµÄÌÛÍ´·´Ó¦Ê±£¬ÆäÐÐΪģʽ·¢ÉúÁ˸ıä
£¬Òò´ËÎÒÃÇÍƶÏÌÛʹѶϢ¿ÉÄÜ¿ÉÒÔÔÚ´óÊó¸öÌåÖ®¼ä´«µÝ¡£

¡ò¡ò´àÈõ¹úÍÁÓëÓÀÐøÖÎÀí-µØÖÊÔÖº¦µÄ̽ÌÖ¡ò¡ò
¼Æ»­Ö÷³ÖÈË ºúÖ²Çì/µØÖÊ¿ÆѧϵËù
¼Æ»­·¢±íÈË ºúÍðÁÕ/µØÖÊ¿ÆѧϵÈýÄ꼶

ĪÀ­¿Ę̈·çÔÚ¸ßÆÁϪÉÏÓεØÇø¾Í·¢ÉúÁ˽üһǧÎå°Ù´¦µÄ±ÀËú£¬×ÜÃæ»ý¸ß´ï
59 ƽ·½¹«ÀÆäÖÐÒÔСÁÖ´åÉÏ·½µÄÏ׶Çɽ±ÀËú£¬³¬¹ý2 ǧ3 °ÙÍòÁ¢·½¹«³ßµÄÍÁ
ʯÔì±ÀËú£¬Ôì³É½ü500 È˱»ÑÚÂñ×îÁîÈËÖõÄ¿¡£Ôì³ÉÑÏÖØËÀÉ˵ĹؼüÔÚ춱ÀËú¹ý
³ÌÖеĵØÐθı䣬¶ø±¾Ñо¿¼Æ»®ÒÔPFC ÈýάÊýֵģÄâµÄ·½·¨£¬Ì½ÌÖ²»Í¬µÄµØÐÎ
ËùÔì³ÉµÄ¶Ñ»ýÇø²îÒì¡£

½á¹û£ºÒÀ¾ÝÄ£Äâ½á¹û·¢ÏÖ£¬590 ¸ßµØµÄ´æÔÚÈñÀÂäµÄ¿éÌåÓÐÒ»¸ö»º³åµÄ¿Õ¼ä£¬¶ø
ÇÒÄÜʹ´ó¶àÊýµÄÑÒ¿éתÏòÁ÷ÈëСÁÖ´å±±²àµÄϪ¹µ£¬µ«ÓÉ춿éÌåµÄÌå»ýʵÔÚÌ«
´ó£¬ÇÒ¶¯Äܼ«´ó£¬Ê¹µÃ590 ¸ßµØ¿ÉÄÜÔں̵ܶÄʱ¼äÄھͱ»Ï÷µôÒ»´ó°ë£¬Ôì³ÉÑÒ
мֱ½ÓÁ÷ÈëСÁÖ´åÄÚµÄDF006 ºÅÍÁʯÁ÷DZÊÆϪÁ÷£¬²¢Á¢¼´´óÁ¿ÒçÁ÷£¬½«Ð¡ÁÖ´å
Ñڸǡ£Èô590 ¸ßµØûÓб»¹Îµô£¬´ó²¿·ÝµÄÍÁʯ¿ÉÄÜ»áתÏòÁ÷ÈëСÁÖ´å±±²àµÄÇÖ
Ê´¹µ£¬²¢ÇÒ½«Ïª¹µ¶Ñ»ýÂú¡£

¡ò¡ò´àÈõ¹úÍÁÓëÓÀÐøÖÎÀí-´óµØ¹¤³Ì¡ò¡ò
¼Æ»­Ö÷³ÖÈË ÁÖÃúÀÉ/ÍÁľ¹¤³Ìѧϵ
¼Æ»­·¢±íÈË ÁÖÙ«Èå¡¢³ÂÓîµÂ¡¢ÑîÊ¿ÏÍ¡¢Ò×µÂȪ/ÍÁľ¹¤³ÌѧϵÈýÄ꼶

±¾¼Æ»­Ëù¿ªÉèÖ®¿Î³Ì¡ºÈËÎÄ¡¢»·¾³Ó빤³Ì¡»£¬½ñÄê³ýÁËÍÁľϵ¡¢µØÖÊϵÓëµØÀíϵµÄѧÉúÖ®
Í⣬ÉõÖÁÓÐÍâУµÄѧÉú¼ÓÈ룬˶¡¢²©Ê¿°àѧÉúÒàÓÐÐí¶àѧÉú²Î¼Ó£¬Ê¹Õû¸ö¼Æ»­µÄ¿ÉËÜÐÔÌá
¸ßÐí¶à£¬¹æ»­Ñо¿ÒéÌâÓë³ï±¸Ò°ÍâµÄÄÜÁ¦¶¼ÌáÉýÁË£¬¶Ôì¶ÎÊÌâµÄÕÆÎÕ¶ÈÒ²¿ªÊ¼ÓÉ×ÊÁÏ¡õ¼¯
Àí½â¿ªÊ¼Ë¼¿¼ÈçºÎ·ÖÎöÓë¡õÇåÒéÌ⣬²¢Ñ°ÕÒ¿ÉÄܵÄ×ÛºÏÐÔ´¦Àí·½°¸¡£

ÕâѧÆڵĿγ̹滮ÓëÒ°ÍâÏÖ¿±·ÖΪ¡¸»·¾³×ÜÂÛ¡¹¡¢¡¸·ÀÔÖÒéÌ⡹Ó롸ˮ×ÊÔ´ÒéÌ⡹Èý´óÖ÷
Ì⣬¹æ»­¶«±±½ÇÑØ°¶µØÇøÖ®×ÔÈ»µØ¾°ÓëÈËÎĵؾ°Î¬»¤¡¢ÐµêϪôä´äË®¿â¼¯Ë®ÇøÓëÑØ°¶·Àºé
¡¢³ÂÓÐÀ¼ÏªÁ÷ÓòÍÁʯÁ÷ÓëºÓ½×¾ÛÂ俪·¢µÈÈý´Î¿Î³ÌÒ°Í⡣ѧÉúÃÇÔÚÒ°ÍⶼÄܶԲ»Í¬ÎÊÌâ·¢
±í×Ô¼ºµÄ¿´·¨£¬²¢½ø¶øÓ벻ͬϵµÄͬѧ»¥Ïàѧϰ¡¢ÌÖÂÛ£¬´ïµ½¿çÁìÓò½ÌѧµÄЧ¹û¡£

¡ò¡òÑо¿Á÷¸Ð²¡¶¾ÌØÐÔÓëÖ²¡»úÖÆ¡ò¡ò
¼Æ»­Ö÷³ÖÈË ÕÅÈðÒË/¶«»ª´óѧÉúÃü¿ÆѧϵôßÉúÎï¼¼ÊõÑо¿Ëù
¼Æ»­·¢±íÈË Ö콨ѫ¡¢ÁÖÁ¼ÐË¡¢ÔøÒâæÃ(¶«»ª´óѧÉúÃü¿Æѧϵ)

ËäȻԤ·ÀÖØì¶ÖÎÁÆ£¬µ«ÊDz¡¶¾ÐòÁб仯¿ìËÙ£¬ÐµÄÍ»±äÖê²»¶ÏµØ²úÉú£¬ÍùÍùÔì³ÉÈËÃǵÄÊÖ
×ãÎ޴룬Òò´ËÓÐЧ¶øÕýÈ·µÄ¼ì²â·½·¨ÊǶԿ¹²¡¶¾µÄÊ×ҪĿ±ê¡£Á÷ÐÐÐÔ¸Ð𲡶¾ÊÇÔì³ÉÈËÀà
¼°¶¯ÎïºôÎüµÀ¼²²¡µÄÒ»ÖÖRNA²¡¶¾£¬ÆäÖм×ÐÍÁ÷¸Ð²¡¶¾ÊDZäÒì×îΪƵ·±µÄÒ»¸öÀàÐÍ£¬Ã¿¸ô
Ê®¼¸Äê¾Í»á·¢ÉúÒ»¸ö¿¹Ô­ÐÔ´ó±äÒ죬²úÉúеĶ¾ÐÔ²»Í¬Ö®²¡¶¾Öê¡£±¾Ñо¿ÀûÓÃÉúÎï×ÊѶѧ
µÄ·ÖÎö·½·¨£¬Ñ¡È¡»ùÒò¿âÖи߲¡Ô­ÐÔ(virulent)ÓëµÍ²¡Ô­ÐÔ(avirulent)²¡¶¾Ö®ÐòÁнøÐÐ
·ÖÎö±È¶Ô£¬µÃµ½ÒÔϽáÂÛ: (i)ÑÝ»¯Ê÷½á¹û¸ßµÍ²¡Ô­ÐÔ²¡¶¾·ÖÊô²»Í¬µÄ¾ÛÂä(cluster);
(ii)ÕÒµ½ÊýÖÖÏÞÖÆ–¡õrestriction enzymes)ÇÐ룬¿ÉÒÔÀûÓÃÏÞÖÆ–£Ý¡õq¶àÐÍÐÔ
(Restriction Fragment Length Polymorphism, RFLP)Çø±ð¸ßµÍ²¡Ô­ÐÔ²¡¶¾; (iii)ÕÒ³ö
¸ßµÍ²¡Ô­ÐÔ²¡¶¾ÐòÁÐÌØÒìÐÔµÄƬ¶Î£¬Éè¼Æ³ö¡õ±ð̽Õë(diagnostic probe)Çø±ð¸ßµÍ²¡Ô­ÐÔ
²¡¶¾¡£ÕâЩ½á¹û¿ÉÒÔ×÷ΪδÀ´¿ÉÄܵĿìɸ·½·¨¡£

¡ò¡ò¿çÁìÓò¡º»îϸ°ûÓ°Ïñ¡»×¨Ìâѧϰ¡õÀûÓÃÊýλȫÏñÏÔ΢ÉãӰʵÑéƽ̨Á¿²â¡¸µÚÈýÐͼ¹Ëè
СÄÔήËõÖ¢¡¹Ï¸°ûģʽ֮ѡֳ¼°Ò©Îïɸѡ¡ò¡ò
¼Æ»­Ö÷³ÖÈË Ð»Ðã÷/̨Íåʦ¡õ´óѧÉúÃü¿Æѧϵ
¼Æ»­·¢±íÈË ³ÂÓôÎÄ¡¢Áν¡²©¡¢ÁÖÁ¢¡¢Ñîºë°²¡¢ÁÖͤ¡¢ÕÅÔÊ¡õ¡¢Î¤»áæ¥(ÉúÃü¿Æѧ
        ϵ)¡¢ÁÖË´ÄС¢ÏôÖÐΰ(»úµç¿Æ¼¼Ñ§Ïµ)

µÚÈýÐÍСÄÔήËõÖ¢(Spinocerebellar ataxia 3, SCA3)Ϊ31ÖÖСÄÔ¼¹ËèήËõÖ¢ÖÐ×î³£¼ûµÄ
Ò»ÖÖ£¬³£¼ûµÄÖ¢×´°üº¬£¬Ô˶¯Ê§µ÷£¬Åо಻Á¼£¬¹¹ÒôÀ§ÄÑ£¬ÊÓ¾õÕÏ°­£¬ÑÛÇò²ü¶¯µÈµÈ£¬ÔÚ
Ê®ÍòÈËÖлáÓÐÈý¸öÈËî¾»¼ÕâÖÖ¼²²¡¡£ÔÚMJD1»ùÒòÉÏ£¬¿¿½ü3¡¯µÄλÖûáÓÐCAGÖظ´µÄÏÖÏó£¬
¾­¹ýתÒëÓëת¼×÷ÓÃáᣬ»áÔÚAtaxin-3µ°°×ÖÊÉÏ¿¿½üC¡¯¶ËµÄλÖÃÓÐôïõµ°·(Glutamine)ÖØ
¸´µÄÏÖÏó£¬Õý³£È˵ÄÖظ´ÊýÔÚ12-37¸ö¼ä£¬¶ø¹ý¶ÈÀ©ÔöÊýÔòÔÚ61-84Ö®ÖУ¬µ±¹ý¶ÈÀ©Ôöʱ£¬
»áÔÚϸ°ûºËÖÐÔì³É¾ÛºÏ(aggreation)£¬½ø¶øµ¼ÖÂϸ°ûµÄËÀÍö¡£ÎÒÃÇËùʹÓõÄÊÇʵÑéÊÒÒѽ¨
Á¢ºÃµÄSCA3ÔÚ´óÊóÉöÉÏÏÙÊȸõϸ°û(Rat adrenal pheochromocytoma, PC12)ÖÐÓÕµ¼±íÏÖµÄ
ϸ°ûģʽ£¬¹Û²ìÔÚ¼ÓÈëÉñ¾­Éú³¤Òò×Ó(Nerve growth factor, NGF)Ö®áᣬÒÔ¼°Í¶ÈëÒÒÏ©»¯
ÒÖÖÆÒ©Îï(LBMX)áᣬϸ°ûneuriteÉú³¤µÄÇé¿ö£¬ÒÔ¼°Ï¸°ûÈýάÐÍ̬µÄ·ÖÎö¡£

¡ò¡ò̽ÌÖbigh3µ°°×µÄÉúÎ﹦ÄÜ¡ò¡ò
¼Æ»­Ö÷³ÖÈË ÎÌ·Ò»ª/ÑôÃ÷´óѧÉúÃü¿Æѧϵôß»ùÒòÌåÑо¿Ëù
¼Æ»­·¢±íÈË Ê©²·ÔÆ/ÉúÃü¿Æѧϵ

¦Âigh3(TGF¦ÂŸ¡õnduced geneŸ¡õ3), is an extracellular matrix protein,which
regulates cell proliferation, differentiation, wound healing,cellŸ¡õell
adhesion and apoptosis. The expression of ¦Âigh3 is regulated by TGF¦Â3, a
critical signaling protein regulates embryonic palate development. Recently,
¦Âigh3 was reported to regulate apoptosis during embryonic palate fusion,
infer that TGF¦Â3 may regulate embryonic palate fusion through upregulating ¦Â
igh3. Interferon regulatory factor 6 (IRF6) is a transcriptional factor which
also involves in embryonic palate fusion. Mutations in IRF6 cause Van der
Woude syndrome and popliteal pterygium syndrome, both of which show defects
in embryo palate fusion and epidermis fusion. However, the biological
function of IRF6 is still not clear. According to the predicted protein
functional domain, IRF6 may interact with Smad, an important signaling
protein in TGF¦Â3 pathway, suggesting that ¦Âigh3, IRF6 and TGF¦Â3 may
cooperate to regulate palate development. To investigate the crosstalk within
¦Âigh3, IRF6 and TGF¦Â3 and the mechanisms that they regulate palate
development, we focus on searching the downstream genes of IRF6 in this
study. We first searched the downstream target genes of IRF6 with predicted
IRF6 binding consensus sequences by bioinformatics methods, and derived 12
candidate genes. Then we analyzed the expression changes of these target
genes after knockdown or overŸ¡õxpression of IRF6 gene in epithelial cells.
Our results indicated that mRNA of NAPEPLD, PSRC1, DYRK1A, KIAA1841, CLDN23,
BUB1, IFIT5 and NBR1, as well as the BUB1 protein were upŸ¡õegulated by IRF6
overexpression in HEK293T cell line. While the mRNA of KIAA1841, CLDN23, BUB1
and NBR1 were downŸ¡õegulated when IRF6 expression was knockdown in CE48T/VGH
cells. These data suggesting that KIAA1841, CLDN23,BUB1 and NBR1 maybe the
downstream target genes of IRF6,however,the roles of these genes in embryonic
palate fusion still need further investigation.
2011/01/16 Sun 13:09:58
»Ø¸² | ת¼Ä | ·µ»Ø

¡õ ̨´óʨ×Óºð·ðѧרվ  http://buddhaspace.org